Roxane Laboratories, Inc. announced today the approval of their Abbreviated New Drug Application for Levetiracetam Tablets, 250mg, 500mg, 750mg, 1000mg, and Oral Solution 100mg/mL. The product is available for immediate shipment to wholesalers and pharmacies nationwide.
The details can be read here.
No comments:
Post a Comment